WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday. The stock traded as high as $27.80 and last traded at $27.80, with a volume of 220 shares changing hands. The stock had previously closed at $26.48.
Analysts Set New Price Targets
Separately, Zacks Research upgraded shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to MarketBeat.com, WuXi AppTec presently has an average rating of “Strong Buy”.
Read Our Latest Stock Analysis on WUXAY
WuXi AppTec Stock Up 3.1%
About WuXi AppTec
WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.
The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.
Featured Stories
- Five stocks we like better than WuXi AppTec
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
- 3 Emerging Biotech Stocks With Significant Upside Potential
- Treasury Yields Haven’t Been This High Since 2007—3 ETFs to Watch
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
